Ó¢¹úThe Binding Site ¹«Ë¾ ¡¤ ¹ú¼ÊÁìÏȼ¼Êõ
                                                     FreeliteÈ«ÇòΨһ²â ¶¨ÑªÇåÖеÄÓÎÀëÇáÁ´ÊÔ¼ÁºÐ
                                      ÊÀ½ç¶À´´¡ª¡ª ²â¶¨ÑªÇåÖеģºÓÎÀëKÇáÁ´ºÍÓÎÀë¦ËÇáÁ´
 
ÓÃÓÚ¶à·¢ÐÔ¹ÇËèÁöµÄÔçÆÚÕï¶Ï

  1. ±ÈÒ»°ãÏÖÓеķ½·¨ÌØÒìÐÔ¸ß
  2. ÌáÔçÕï¶Ï2-3Äê

 ÊÀ½çÉ϶À¼ÒÉú²ú²â¶¨ÑªÇåÖеÄÓÎÀëKÇáÁ´»ò/ºÍÓÎÀë¦ËÇáÁ´µÄÊÔ¼Á

1. ѪÇåÓÎÀëKÇáÁ´ÊÔ¼ÁºÐ

2. ѪÇåÓÎÀë¦ËÇáÁ´ÊÔ¼ÁºÐ

 ÁéÃô¶ÈºÍÌØÒìÐԺܸß,Ö±½Ó²â¶¨. ĿǰÔÚÅ·ÃÀ·¢´ï¹ú¼ÒÒÑÔÚ¹ã·ºÍÆ¹ãÓ¦ÓÃ
 
ĿǰÔÚÖйúÖ»Äܲⶨ×ܵÄKºÍ¦ËÇáÁ´¡£²»ÄÜ·Ö¿ª²â¶¨ÓÎÀëµÄ.ÓÃÄòÒº²â¶¨,Ö»ÄܲâµÃ¼ä½ÓµÄ½á¹û,²»×¼È·.
 
¶à·¢ÐÔ¹ÇËèÁöÔçÆÚÕï¶Ï

 ¹ú¼ÊµÚÒ»¼ÒÈ«¶¨Á¿ ²â¶¨ ѪÇåÖÐ µÄÓÎÀëKÇáÁ´ºÍѪÇåÖеÄÓÎÀë¦ËÇáÁ´
 
È«¶¨Á¿ÑªÇåÖеÄÓÎÀëKÇáÁ´ºÍѪÇåÖÐÓÎÀë¦ËÇáÁ´µÄ²â¶¨£ºFreelite £º

 ¶à·¢ÐÔ¹ÇËèÁöÔçÆÚÕï¶Ï

»õ ºÅ

ÊÊÓûúÐÍ

¹æ ¸ñ

ÓŻݼ۸ñ

LK016.T
LK018.T

×ÔÓÉKÇáÁ´ÊÔ¼ÁºÐ Dade-Behring BNIIÌØÖÖµ°°×ÒÇ
×ÔÓɦËÇáÁ´ÊÔ¼ÁºÐ Dade-Behring BNIIÌØÖÖµ°°×ÒÇ

2¡Á50T
2
¡Á50T

6500
6500

LK016.IM
LK018.IM

×ÔÓÉKÇáÁ´ÊÔ¼ÁºÐBeckman ImmageÌØÖÖµ°°×ÒÇ
×ÔÓɦËÇáÁ´ÊÔ¼ÁºÐBeckman ImmageÌØÖÖµ°°×ÒÇ

2¡Á50T
2
¡Á50T

6500
6500

LK016.H
LK018.H

×ÔÓÉKÇáÁ´ÊÔ¼ÁºÐHITACHI ÈÕÁ¢·ÖÎöÒÇ
×ÔÓɦËÇáÁ´ÊÔ¼ÁºÐHITACHI ÈÕÁ¢·ÖÎöÒÇ

2¡Á50T
2
¡Á50T

6500
6500

LK016.AU
LK018.AU

×ÔÓÉKÇáÁ´ÊÔ¼ÁºÐOLYMPUS·ÖÎöÒÇ
×ÔÓɦËÇáÁ´ÊÔ¼ÁºÐOLYMPUS·ÖÎöÒÇ

2¡Á50T
2
¡Á50T

6500
6500

RN015.3

×ÔÓÉKÇáÁ´Kappa-Free and Bound

14¿×¡Á3°å

2600

RE016.3

×ÔÓÉKÇáÁ´Kappa Free

14¿×¡Á3°å

2600

RN017.3

×ÔÓɦËÇáÁ´Lambda-Free and Bound

14¿×¡Á3°å

2600

RE018.3

×ÔÓɦËÇáÁ´Lambda-Free and Bound

14¿×¡Á3°å

2600

 

Ãâ Òß À© É¢(RID)·¨ ¼ì ²â ÊÔ ¼Á

²ú Æ· ±à ºÅ

²ú Æ· Ãû ³Æ

¼ì ²â ·¶ Χ(mg/L)

°ü ×°

RN106.3

IgG1-SDÊÔ¼ÁºÐ

1400-14000

14¿×¡Á3°å

RN107.3

IgG2-SDÊÔ¼ÁºÐ

800-8000

14¿×¡Á3°å

RN108.3

IgG3-SDÊÔ¼ÁºÐ

120-1200

14¿×¡Á3°å

RN109.3

IgG4-SDÊÔ¼ÁºÐ

50-500

14¿×¡Á3°å

RK021

IgG1,2,3,4-SDÁªºÏ¼ì²âÊÔ¼ÁºÐ

14¿×¡Á4°å

RN087.3

IgA1-NLÊÔ¼ÁºÐ

638-6380

14¿×¡Á3°å

RN088.3

IgA1-NLÊÔ¼ÁºÐ

51-510

14¿×¡Á3°å

RK015

IgA1,2-NL.ÊÔ¼ÁºÐ
(IgA1,2
¸÷Á½°å,±ê׼ƷµÈ)

14¿×¡Á4°å

RN013.3

IgD-NL.ÊÔ¼ÁºÐ

14¿×¡Á3°å

GT014.3

IgE    ÊÔ¼ÁºÐ

14¿×¡Á3°å

RN015.3

Kappa-Free and Bound

14¿×¡Á3°å

RE016.3

Kappa Free

14¿×¡Á3°å

RN017.3

Lambda-Free and Bound

14¿×¡Á3°å

RE018.3

Lambda-Free and Bound

14¿×¡Á3°å

Ѫ Äý Òò ×Ó ÊÔ ¼Á

RN040.3

AT-III

14¿×¡Á3°å

GT113.3

Factor XIII

14¿×¡Á3°å

RN056.3

FIB

14¿×¡Á3°å

GT100.3

µ°°×S

14¿×¡Á3°å

GT118.3

µ°°×C

14¿×¡Á3°å

GT054.3

vWF

14¿×¡Á3°å

Ãâ Òß µ° °×

RN019.3

C1 Inactivator

14¿×¡Á3°å

RN020.3

C1q -NL

14¿×¡Á3°å

RN021.3

C1r -NL

14¿×¡Á3°å

RN022.3

C2 -NL

14¿×¡Á3°å

RN023.3

C3 -NL

14¿×¡Á3°å

GT024.4

C3d -NL

14¿×¡Á3°å

RN025.3

C4 -NL

14¿×¡Á3°å

RN026.3

C4 -NL

14¿×¡Á3°å

RN027.3

C5 -NL

14¿×¡Á3°å

RN102.3

C6 -NL

14¿×¡Á3°å

RN103.3

C7 -NL

14¿×¡Á3°å

RN089.3

C8 -NL

14¿×¡Á3°å

RN028.3

C9 -NL

14¿×¡Á3°å

RN029.3

Factor  B

14¿×¡Á3°å

RN030.3

Factor  H(¦Â1H)

14¿×¡Á3°å

RN031.3

Factor  I(KAF)

14¿×¡Á3°å

RN032.3

°×µ°°×

14¿×¡Á3°å

RN032.3

°×µ°°×

14¿×¡Á3°å

RN063.3

¦Á1-Acid Glycoprotein

14¿×¡Á3°å

RN034.3

¦Á1-Antitrypsin

14¿×¡Á3°å

RN036.3

¦Á1-Microglobulin¦Á1΢Çòµ°°×

14¿×¡Á3°å

GT043.3

¦Â2-Microglobulin¦Á1΢Çòµ°°×

14¿×¡Á3°å

±È ×Ç ·¨ ¼ì ²â

ÓÃÓÚBeckman ARRAYÌØÖÖµ°°×ÒÇÑÇÀàÊÔ¼Á£º

²ú Æ· ±à ºÅ

²ú Æ· Ãû ³Æ

¼ì ²â ·¶ Χ(mg/L)

°ü ×°

NK006.E

IgG1 Beckman ARRAYÊÔ¼ÁºÐ

1536-14400

4¡Á50T

NK007.E

IgG2 Beckman ARRAYÊÔ¼ÁºÐ

498-6300

4¡Á50T

NK008.E

IgG3 Beckman ARRAYÊÔ¼ÁºÐ

128-1200

4¡Á50T

NK009.E

IgG4 Beckman ARRAYÊÔ¼ÁºÐ

89-1050

4¡Á50T

NK001.E

IgG1,2,3,4 Beckman ARRAYÁªºÏ¼ì²âÊÔ¼ÁºÐ

4¡Á50T

AD002

ÓÃÓÚBeckman ARRAY¼ì²âµÄУÕýºÍ¼ÆËãÈí¼þ(¿É×Ô¶¯½«ARRAYÒÇÆ÷ÉϵÄËÙÂÊÊý¾ÝÏÂÔØµ½¼ÆËã»úÉϲ¢×Ô¶¯×ª»¯ÎªÑùƷŨ¶È)

1¡Á3.5ÈíÅÌ

NK006IM

Beckman Immage IgG1 KiT

 

NK007IM

Beckman Immage IgG2 KiT

 

NK008IM

Beckman Immage IgG3 KiT

 

NK009IM

Beckman Immage IgG4 KiT

 


ÓÚBehring(BNA£¬BNII)µ°°×±È×ÇÒÇÑÇÀàÊÔ¼Á£º

²ú Æ· ±à ºÅ

²ú Æ· Ãû ³Æ

¼ì ²â ·¶ Χ(mg/L)

°ü ×°

NK006.G

IgG1BNA(·ÇÈ齺)ÊÔ¼ÁºÐ

1875-60000

4¡Á40T

NK007.G

IgG2BNA(·ÇÈ齺)ÊÔ¼ÁºÐ

438-14000

4¡Á40T

NK008.G

IgG3BNA(·ÇÈ齺)ÊÔ¼ÁºÐ

250-4000

4¡Á40T

NK009.G

IgG4BNA(·ÇÈ齺)ÊÔ¼ÁºÐ

88-1750

4¡Á40T

LK009.1G

IgG4BNA(È齺)ÊÔ¼ÁºÐ

55-875

40T

LK009.G

IgG4BNA(È齺)ÊÔ¼ÁºÐ

55-875

4¡Á40T

LK001.G

BNAÁªºÏ¼ì²âÊÔ¼ÁºÐ(È齺IgG4;·ÇÈ齺IgG1,2,3,×ÜIgG)

5¡Á40T

NK001.G

BNAÁªºÏ¼ì²âÊÔ¼ÁºÐ(·ÇÈ齺IgG1,2,3,4,×ÜIgG)

5¡Á40T

NK087.1G

IgA1-BNAÊÔ¼ÁºÐ

375-6000

40T

LK088.1G

IgA2-BNAÊÔ¼ÁºÐ

63-1000

40T

LK003.G

IgA1,2-BNAÁªºÏ¼ì²âÊÔ¼ÁºÐ(È齺IgA2,·ÇÈ齺IgA1,IgA)

3¡Á40T

ÓÃÓÚMININEPHÉ¢Éäµ°°×±È×ÇÒÇÑÇÀàÊÔ¼Á£º

²ú Æ· ±à ºÅ

²ú Æ· Ãû ³Æ

¼ì ²â ·¶ Χ(mg/L)

°ü ×°

ZK006.R£» ZK007.R

IgG1£»IgG2ÊÔ¼ÁºÐ

1440-23000£» 770-12380

10T

ZK008.R£» ZK009.R

IgG3£»IgG4ÊÔ¼ÁºÐ

153-2450£»88-1388

10T

ZK087.R£¬ ZK088.L.R

IgA1£¬IgA2ÊÔ¼ÁºÐ

330-5300£¬ 81-1300

10T

»¹ÓÐÆäËûÐí¶àÊÔ¼ÁδÁгö£¬ÇëÏò¹«Ë¾×Éѯ¡£
ÓÃÓÚDATE BEHRING BNII,BECKMAN IMMAGE,HITACHIµÈÒÇÆ÷ÉϵÄIgG¡¢IgAÑÇÀà¼ì²âÊÔ¼Á,ÇëÏò¹«Ë¾²éѯ

 




µÂ¹úÃÀ´´¹«Ë¾ÖйúÉÌÎñÖÐÐÄ
µç»°£º010£­67300929£¬67308077£¬67308089 ÈÈÏߣº13801352044 ´«Õ棺010£­67308090
ÍøÖ·£ºwww.mdcbj.com  E-mail£ºmdcbeijing@163.com